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two phase culture system that enables the distinction between the 
expansion of early and late progenitors. In the first phase (3 
weeks), the cultures were supplemented with both TEPA and 
cytokines (FLt3, SCF, TPO, IL-6). In the second phase (addition- 
al 5-7 weeks) the cultures were supplemented with cytokines 
alone, in the absence of TEPA. Late progenitors (CD34+ and 
CFUc) as well as early progenitor cells (CD34+CD38-, 
CD34+Lin-(CD38, 33, 14, 15, 61, 41, 3, 4, 19), CD34+38-HLA- 
DR-) were measured at the termination of the treatment phase 
(week 3) as well as at different intervals during the long-term assay 
phase. After the first phase (3w), TEPA cultures contained signifi- 
cantly higher percentages of early progenitors (21% CD34+38- 
+/- 3.8; 7.0% CD34+Lin- +/-1.9, 1.5%+/-0.5 CD34+38-HLA- 
DR, n=9-) as compared to the control, only cytokine treated cul- 
tures (2.6% CD34+38- +/ 1, 0.9% CD34+Lin- +/-0.3, 0% 
CD34+38-HLA-DR- n=9 ). At the same time, no differences were 
noticed in the late progenitors (TNC, CFUc and CD34+ cells) 
between control and TEPA cultures. Fold expansion of CD34+ 
ceils in both control and treated cultures was in the range of 10-40 
(N=6) folds. After the second phase (additional 5-7w) in the 
TEPA pre-treated cultures, CD34+ cells expanded by 370-1320 
folds (N=6) whereas no CD34+ cells could be recovered in control 
cultures. CFUc expansion i  TEPA pre-treated cultures was by 20 
to 30 folds (n=6) higher than in the control cultures. These results 
indicated that the chelator enabled preferential proliferation of 
early progenitors during the first three weeks. At this stage, no 
positive or negative ffect on the expansion of late progenitors and 
TNC was obsmwed. These early progenitors continued to prolif- 
erate and differentiate during the TEPA free phase and supported 
the extensive xpansion of late progenitors during the long term 
cultures.The chelator based method of three weeks ex vivo expan- 
sion, which resulted in a cell graft enriched in early progenitors 
increased by 10 told the engraftment in SCID mice. We plane to 
test the safety and efficacy of such a graft in clinical cord blood 
transplantation. 
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THE PRESENCE CXCR4 ON CD34+ CELLS WAS ASSOCIATED WITH 
THE EFFECTIVENESS OF G-CSF PBPC MOBILIZATION 
Lange, A.; Dlnbek, D.; Skrzypele, D.; Pacuszko, T. B3/IT Unit, Lov:er 
Sile,@m C2,ntre for Celhdar Tiwlspla77tation/Institute of l~nm'm~olo~y 
and Experimental Therapy, WROCL4 ~V, Polmzd. 
The presence of CXCR4 on CD34+ cells plays a role in 
hematopoietic progenitors rafficking" and reflects the stage of 
these cells dif ferentiat ion. The most primitive cells are 
CXCR4 strongly positive than they loose this epitope and 
gain it again while become DR positive. Therefore, we inves- 
tigated the proportions of CXCR4+ and DR+ cells among 
CD34+ cells in ninety G-CSF mobilized leukapheresis prod- 
ucts (PBPC) obtained from fifty eight volunteer, healthy 
donors and in thirty one bone marrow harvests (BM) for allo- 
geneic grafting'. Marrow transplant materials differed from 
PBPC with respect to the proport ions of CD34+ cells 
(0.91%+-0.07 vs 0.64%+-0.04, p=0.001) which were, however, 
to the similar proport ion DR negative (14.15%+-1.81 vs 
13.89%+-1.44). Looking at the co-expression of CXCR4 and 
DR on CD34+ cells, it was found that PBPC CD34+ cells 
were more frequently CXCR4-DR+ as compared to marrow 
(48.42%+-2.45 vs 39, 34%+-4.38, p=0.05). Marrow CD34+ 
cells were more frequently CXCR4+ than those in PBPC 
(62.47%+-4.09 vs 50.91%+-2.47, p=0.02). PBPC preparations 
were richer in CD34+ cells if the latter cells were in higher 
proportions CXCR4 negative (r=0.45, p=0.00001), in variance, 
marrows harvested for transplantation contained more CD34+ 
cells if they were CXCR4+ (r=0.34, p=0.06) It may be con- 
cluded that the presence of CXCR4 on CD34+ ceils influ- 
enced the yield of transplant material in hematopoietic pro- 
genitors. The coexopression of CXCR4 on CD34+ cells made 
the marrow harvest richer in hematopoietic progenitors but 
the content of CD34+ cells in G-CSF mobilized PBPC signif- 
icantly depended on the presence of CD34+ cells lacking 
CXCR4. 
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SIBLING DONOR CORD BLOOD (SDCB) BANKING AND TRANSPLAN- 
TATION FOR CHILDREN WITH SICKLE CELL ANEMIA AND THA- 
LASSEMIA: CHILDRENS HOSPITAL OAKLAND SIBLING DONOR CORD 
BLOOD PROGRAM, 
Lubin, B.H.: Reed, ~'V.; f'Valte'rs, M. ChildreJ~'s ttospirnl Oakland 
Research bzstitnte, Oakland, CA. 
Sickle cell anemia nd thalassemia are two genetic diseases with 
a worldwide incidence. Vffhile current reatment protocols for 
these patients have improved their lives, hematopoctic stem cell 
(HSC) transplantation is the only current reatment that offers a 
promise of cure. The donor for a HSC transplant is most often an 
HLA matched sibling. Recent evidence suggests that umbilical 
cord blood (CB), obtained from a sibling, may provide an impor- 
tant source of HSCs for these transplants. \Ve have developed a
National SDCB Banking program to provide a resource to evalu- 
ate CB transplantation. Our bank has fascilitated the collection of 
over 200 CB samples for families who already had a child with 
sickle cell anemia or thalassemia.. The volume of CB (average 100 
ml) collected and the nucleated cell counts were sufficient o pro- 
vide at least 2.5x107 cells/kg recipient weight in 85% of the cases. 
Taken together with recent results reported by NETCORD, a 
total of 44 children with henroglobinopathies (33 thalassemia, 11 
sickle cell anemia) have been transplanted with HLA matched 
SDCB. 85% appear to have been cured. The remaining children 
failed to engraft and had a return of disease. Minimal GVHD was 
noted. None of the children died as a result of the transplant. 
~eVhile acommon transplant protocol was not followed, our results 
suggest that modification of the conditioning regimen and provid- 
ing a critical nucleated cell dose will enhance ngraftment and 
improve outcome. We conclude that SCDB banking should be 
available to all families who currently have a child with sickle cell 
anemia or thalassemia. A prospective study to determine the opti- 
mal regime for SDCB transplantation is currently underway. 
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OPTICAL IMAGING OF EARLY POST-TRANSPLANT DESTINY OF BONE 
MARROW PROGENITOR CELLS IN MICE 
Doubrovin, 3/[.M. I; 3/layer-R)Mezdc, p.2; B~ldak ~tlpogalz, T. i; Vm~ cle~7 
Brink, M.1; BaJze~jee, D.~; GelovaJTi Tjltvnjev, ft.1 1. Nez~rology, 
3/ISKCC, New ~rk, NY," 2. The Cancer bzstitute New fferse~, Robert 
~'Vood ffohlTsolz ]VIedical School, New Brmzs'wick, Nff. 
Use of non-invasive isualization techniques to follow up the 
destiny of transplanted hematopoietic stem cells provide a reliable 
tool for investigation of the processes of transplant engraftment 
and reconstitution of hematopoiesis. Bone marrow, harvested 
from C57BL/6-Ly.1 donor mice, was negatively sorted for differ- 
entiation determined c lls. The obtained enriched population of 
bone marrow precursor cells (BMPC) was stably transfected with 
ecotropic retrovirus carrying TK-dmDHFR and GFP-Luc 
chimeric genes. Transfected cells were positively selected on 
FACSVantage using GFP-expression signal. 10A4 BMPC were 
reinfused as a rescue of lethally irradiated C57BL/6-Ly.2 recipient 
mice. D-lueiferin was administered either in vivo, immediately 
post-transplant, or ex vivo, directly to the BMPC, in two animal 
groups: Bioluminescent imaging (BLI) was started in 5 minutes 
after the BMPC. For the follow up studies, d-luciferin was admin- 
istered I.V. to all animal groups. Control group included irradiat- 
ed animals without BMPC support. BLI revealed a weak, but dis- 
tinctive signal accumulation in the projection of lungs and 
mediastinum with animals in supine position. Dilution of BMPC 
local concentration resulted in disappearance of any detectible sig- 
nal between hours 36 and 60. Further obsmwation demonstrated 
BMPC localization to the final hematopoietic sites. Higher signal 
was registered in the animals inoculated with the ex vivo d- 
lueiferin preineubated BMPC. No specific signal was identified in 
the control group. ~/Veak sources of photons associated with the 
projection of open skin/mucosa areas corresponded to the subin- 
flared thermal photon background. Early migration of a small 
nmnber of stem cells can be efficiently monitored using highly 
sensitive bioluminescence approach. Systemic BMPC dose lower 
limits for sensitivity of BLI registration were identified. Triple 
130 
Poster  P resentat ions  - Sess ion  I I  
reporter-gene system applied in this study contributed to reduc- 
tion of required ex vivo BMPC culture maintenance time and 
more flexible study design. 
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ROLE OF GRAFT-FACILITATORY CELLS IN HUMAN ENGRAFTMENT IN 
THE NOD-SCID MOUSE MODEL 
Rice, A.Md; Ramivez, C.Dd; I,~'%cI, ~.A.:; NovdoT~, R.E. ~ 1. Ca,cer 
Biotberapy, 3/later k/lecliatl Reseavela I ,  stimte, So~t,~ Brisbane, QLD, 
A,stralia; 2. C,bildre,l ~" Cancer I ,  stitl~te AHStralia, RaJldzvick, NSD ~, 
A,strnlia; 3. Gva&mte School f Biomedical EJlgi, eeri,g, ghfivelsity of
NSH 7, Rm~dwide, NS~'V, Australia. 
We used the NOD-SCID naouse model to study factors that 
effect engraftment of human cord blood (CB) stem cells. Previous 
work showed that non-engrafting CD34 filler cells must be co- 
transplanted with unexpanded CB CD34 + cells to detect human 
cells in the NOD-SCID mouse. MACS enriched CB CD34 + cells 
were incubated for 7 days with SCF, FLT3 Ligand and MGDF in 
serum free media. Irradiated NOD-SCID mice were transplanted 
with CB CD34 + cells + irradiated CD34- filler cells. Bone marrow 
(BM) and spleen were analysed by flow cytometry for human 
engraftment 6 weeks post transplant. The level of human engraft- 
ment is significantly reduced when more than 107 filler cells are 
co-transplanted with unexpanded CD34 + ceils. We transplanted 
mice with 107 irradiated filler cells and increasing numbers of 
unmanipulated or expanded CB CD34 + cells. Engraftment was 
not increased in mice transplanted with nnexpanded CB CD34 + 
input ceils; however human engraftment increased when mice 
were transplanted with increasing numbers of expanded CB 
CD34 + input cells. We tested the effect of increasing nmnbers of 
irradiated filler cells on the levels of human engraftment in mice 
transplanted with unexpanded and expanded CD34 + cells and 
found that expanded ceils dout require filler cells for engraftment. 
Phenotypic analysis of irradiated filler cells and expanded CD34 + 
cells did not define a specific cell type that could explain the graft 
facilitatory effect. Filler cells facilitate human engraftment when 
mice are transplanted soon after irradiation but are not required 
when transplantation is delayed for 48 hrs, suggesting that 
engraftment of unexpanded CD34 + cells is facilitated by cytokines. 
Unexpanded and expanded CB CD34 + cells have different 
requirements for engraftment in the NOD-SCID mouse. We 
hyt3othesize that expanded cells generate cells or factors that facil- 
itate engraftment. Definition of the underlying mechanism for 
this phenomenon may lead to strategies to facilitate ngraftment 
for transplant recipients. 
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ABC-TRANSPORTER MEDIATED EFFLUX OF ALDEHYDE DEHYDROGE- 
NASE REACTION PRODUCT: IMPLICATIONS FOR ENUMERATION AND 
ISOLATION OF FUNCTIONAL BLOOD PROGENITOR CELLS 
Balbev, A.Ed; GeJlrJ7, Td; P~'itehard, C.I; Ba,co,l, Cd; Dell, errs, E.1; 
Smith, C.A. e 1. SteT, Co Bimnedica/, Ilzc., Davha~J1, NC; 2. Moffitt 
Cm~ce'r Ce,te*, TaJllpa, FL. 
Storms et al [PNAS 96, 9118-9123, 1999] used the aldehyde 
dehydrogenase [ALDH] substrate BAAA to enrich cord blood 
[UCB] hematopoeitic stem and progenitor cells [HSPs], They 
found that the effltLx of BAA, the ALDH reaction product, from 
UCB cells was slowed by verapamil; this is consistent with the 
high activity of ABC-transporters in HSPs. We now report that 
the BAAA method can be used to detect and isolate functional 
peripheral blood [PB] HSPs. Intracellular aecunmlation of BAA 
was stabilized by maintaining labeled PB HSPs on ice or by using 
probencid instead of verapamil to inhibit ABC-mediated efflux. 
BAA efflux was the major source of ALDH assay variability in the 
absence of probenecid. At 2.SmM probenecid, efflux of BAA was 
reduced >95%, and enumeration of PB HSPs could be readily 
accomplished at room temperature. Using probenecid ecreased 
the variability of the ADLH assay at least two-fold and allowed 
robust ALDH based enumeration of PB HSCs over the entire 
dynamic range of clinical stem cell determinations; standards 
yielded an assay CV ranging from 20.4% in samples containing 
0.1% CD34+ cells to 5.6% for samples with 6% CD34+ cells. 
UCB or PB HSPs could be sorted on the basis of ALDH activity 
without exposure to ABC transport inhibitors by carefully main- 
taining cells on ice. After sorting, HSPs were incubated at room 
temperature or 37C to allow efflux of BAA; no residual BAA fluo- 
rescence was detected in sorted PB HSP after 30 minutes at room 
temperature. The ALDH reaction had no effect on the short term 
clonogenic activity of HSPs, and BAAA had no detectable toxic or 
mutagenic effects in standard preclinical assays. No more thai~ 1% 
of cells expressing high ALDH activity, but as ma W as 40% of the 
CD34+ cells, in frozen and thawed UCB or PB HSPs were stained 
by 7AAD. BAA must be retained in cells that stain brightly for 
ALDH, but CD34 may be accessible to antibody on damaged or 
apoptotic eils that do not retain BAA. Thus, if ABC-transporter 
mediated efflux is inhibited, the ALDH method etects functional 
HSPs with high ALDH activity using a single channel of the flow 
cytometer. Efflux of the ALDII product can be controlled uring 
HSP enumeration and isolation and can be used to produce func- 
tional cell populations with low levels of residual BAA for research 
and future clinical applications. 
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EVOLVING EPIDEMIOLOGY OF CANDIDA IN THE BONE MARROW 
TRANSPLANT UNIT: A LOOK TWELVE YEARS AFTER FLUCONAZOLE 
Little, T.B.; ~Vooch-ieh, S.; BoJteov, D.; ZawazvJ, A.; Chandvasehav, 
P.H.; Bapmes, R.; Bone 34a'rrow, 72; Vazq,ez, ~.A. Det'roit Medi~rd 
CeTztet'-T&~aw~e State UMve'rsitv School f 3ledieJTle, De#v#, ~¥II. 
The increasing incidence of non-albicans Candida species, espe- 
cially C. glabvata has been frequently associated with the increase 
in antifungai use, specifically fluconazole. This point prevalence 
study evaluated the current epidemiology and evolution of CaTzdi- 
da species in the era of fluconazole prophylaxis and compared the 
results to a similar study done in 1989/1990, prior to fluconazole 
use. Methods: 92 cultures were obtained in the bone marrow 
transplant unit (BMTU), of these, 42 hand cultures from 2 i 
healthcare workers (HCVO and 50 environmental samples (ES) 
taken from patient care areas. Hand cultures were obtained by 
handwashing technique in YEPD broth. ES were obtained using 
Sabouraud extrose Rodac plates. Yeast specimens were evaluated 
for genus/species identification and in vitro susceptibilities were 
done using the disk diffusion technique for fluconazole (FLZ) and 
voriconazole (VCZ) and the NCCLS methodology for FLZ, 
VCZ, amphoteriein B (AraB) and mieafungin (Mfg). We also 
reviewed our positive blood cultures for yeast for Jan-Dee 1989 
and Jan-Dec 2001. Results: There were 18/42 (43 %) positive cub 
aires for yeast from the HCW hand cultures, 4/18 C. albica,s (Ca), 
ll/18C.pavnuilosis (Cp), 1/18 C.glabrata (Cg), and 1/18 for C. h@v 
(Ck). In 1989 only 4/25 (16%)of hand cultures were positive for 
yeast, all were Cp. Of the 50 ES, all were negative for yeast. 
Whereas, in I989, there were 10 ES (+) for yeast, 5 Ca, 1 Cg, 1 
C.gtlilliermomtii, 3 C.bzsitmfiae (CI). Blood culture results from 
I989 reveal Ca to be the most common, 52%, C. tropicalis (Ct) 
25%, Cp 12%, Cg 9%, and C.~'@'r 1.5%. Whereas in 2001, Ca 
39%, Cg 34%, Cp 18%, Ct 7%, C. lerztsei and C1 i%. In-vitro sus- 
ceptibilities were unchanged in 1989 versus 2002. Discussion: 
Despite the rise in Cg fungemia, the environment fails to be a cul- 
prit in nosocomial Cg colonization and/or in Cg fungemia. Thus, 
FLZ prophyla~s has had no impact on the nosocomial epidemiol- 
ogy of Cg colonization. In contrast, Camliela colonization rates 
especially Cp are nmch higher on HCW hands today, than before. 
This study shows that with FLZ prophylaxis, the in-vitro suscepti- 
bilities have not changed. It is evident, then, that the nosocomial 
transmission of Candida is species pecific. Additional studies are 
needed to elucidate the origins of Cg increasing role in blood 
stream infections today. 
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